Bright Minds Biosciences Inc. (DRUG) Ownership
DRUG ownership summary
as of October 17, 2026- Institutions
- 94.9% of shares outstanding
- Insiders
- 11.94% of shares outstanding
- Shares outstanding
- 9.9M
- Float
- 6.7M shares available to trade
- Short interest
- 11.60% 883K shares short
- Days to cover
- 9.72 short interest down 5.3% vs prior month
- Institutions 94.95%
- Insiders 11.94%
DRUG top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Jupiter Topco LLC | 13.68% | 1.3M | $69.2M | +1.3M (0.0%) | June 30, 2026 |
| 2 | HHG PLC | 13.02% | 1.3M | $65.9M | +128,329 (+11.1%) | March 31, 2026 |
| 3 | Cormorant Asset Management, LLC | 9.12% | 900K | $46.2M | −159,331 (−15.0%) | June 30, 2026 |
| 4 | BlackRock Inc | 6.96% | 686K | $35.2M | +64,251 (+10.3%) | June 30, 2026 |
| 5 | Vivo Capital, LLC | 5.65% | 557K | $28.6M | — | June 30, 2026 |
| 6 | Vestal Point Capital LP | 5.53% | 545K | $28.0M | +52,681 (+10.7%) | June 30, 2026 |
| 7 | BRAIDWELL LP | 4.90% | 484K | $24.8M | −55,886 (−10.4%) | June 30, 2026 |
| 8 | Driehaus Capital Management LLC | 4.39% | 433K | $22.2M | +862 (+0.2%) | June 30, 2026 |
| 9 | Balyasny Asset Management LLC | 3.50% | 345K | $17.7M | +47,895 (+16.1%) | June 30, 2026 |
| 10 | Adage Capital Partners Gp LLC | 3.40% | 335K | $17.2M | −160,743 (−32.4%) | June 30, 2026 |
| 11 | Point72 Asset Management, L.P. | 3.32% | 327K | $16.8M | +327,416 (0.0%) | June 30, 2026 |
| 12 | Deerfield Management Co | 2.87% | 283K | $14.5M | — | June 30, 2026 |
| 13 | RA Capital Management, LLC | 2.69% | 265K | $13.6M | — | June 30, 2026 |
| 14 | Parkman Healthcare Partners LLC | 2.08% | 205K | $10.5M | +164,955 (+411.4%) | June 30, 2026 |
| 15 | MPM Oncology Impact Management LP | 2.05% | 202K | $10.4M | −10,061 (−4.7%) | June 30, 2026 |
| 16 | Wellington Management Company LLP | 1.74% | 171K | $8.8M | +34,638 (+25.3%) | June 30, 2026 |
| 17 | The Goldman Sachs Group Inc | 1.36% | 134K | $6.9M | +59,320 (+79.8%) | June 30, 2026 |
| 18 | Eventide Asset Management, LLC | 1.32% | 130K | $6.7M | — | June 30, 2026 |
| 19 | State Street Corp | 1.24% | 122K | $6.3M | +13,939 (+12.9%) | June 30, 2026 |
| 20 | SEVEN GRAND MANAGERS, LLC | 1.22% | 120K | $6.2M | — | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 11 holders added 2.2M shares and 4 cut 386K.
DRUG top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | iShares Russell 2000 ETF | 1.86% | 184K | $9.4M | −2,112 (−1.1%) | September 30, 2026 |
| 2 | Janus Henderson Hrzn Biotec E2 USD | 1.68% | 166K | $8.5M | — | June 30, 2026 |
| 3 | Eventide Healthcare & Life Sciences I | 1.32% | 130K | $6.7M | — | June 30, 2026 |
| 4 | Heptagon Driehaus US Micro Cap Eq C$ Acc | 1.05% | 104K | $5.3M | — | August 31, 2026 |
| 5 | BlackRock Health Sciences Opps Inv A | 0.97% | 96K | $4.9M | — | August 31, 2026 |
| 6 | Biotech Growth Ord | 0.94% | 93K | $4.8M | +53,000 (+132.5%) | June 30, 2026 |
| 7 | Fidelity Small Cap Index | 0.82% | 81K | $4.2M | +773 (+1.0%) | July 31, 2026 |
| 8 | BGF World Healthscience A2 | 0.76% | 75K | $3.9M | — | June 30, 2026 |
| 9 | iShares Russell 2000 Growth ETF | 0.68% | 67K | $3.4M | −84 (−0.1%) | September 30, 2026 |
| 10 | Fidelity Enhanced Small Cap Core ETF | 0.54% | 53K | $2.7M | +111 (+0.2%) | September 30, 2026 |
| 11 | Vanguard Russell 2000 ETF | 0.43% | 43K | $2.2M | +969 (+2.3%) | August 31, 2026 |
| 12 | Driehaus Micro Cap Growth USD | 0.42% | 42K | $2.1M | — | July 31, 2026 |
| 13 | AdvisorShares Psychedelics ETF | 0.40% | 40K | $2.0M | — | September 30, 2026 |
| 14 | BlackRock Health Sciences Term Trust | 0.32% | 32K | $1.6M | — | June 30, 2026 |
| 15 | Vanguard US Momentum Factor ETF | 0.29% | 29K | $1.5M | +9,701 (+50.6%) | June 30, 2026 |
| 16 | iShares Micro-Cap ETF | 0.23% | 22K | $1.1M | −154 (−0.7%) | September 30, 2026 |
| 17 | Adara Smaller Companies | 0.21% | 20K | $1.0M | — | August 31, 2026 |
| 18 | GS US Sm Cp CORE Eq Base Inc USD Snap | 0.20% | 20K | $1.0M | −2,950 (−13.0%) | July 31, 2026 |
| 19 | Goldman Sachs Small Cap Eq Insghts Instl | 0.19% | 19K | $965,210 | +14,417 (+327.8%) | July 31, 2026 |
| 20 | Schwab Small Cap Index | 0.18% | 18K | $925,042 | — | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
DRUG insider transactions
latest 1| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2024-10-15 | Cormorant Asset Management, Lp | Buy | $5.53 | 372,591 | $2.1M |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
DRUG shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns DRUG
Institutional investors own 94.9% of Bright Minds Biosciences's shares and insiders 11.94%. The largest holder is Jupiter Topco LLC with 13.68% of the shares (1.3M), as of June 30, 2026. Among the top 20 institutions, 11 added shares and 4 reduced their stake in the latest filings. Short interest is 11.60% of the float, or 9.72 days of average trading volume. The share count rose 570.4% since 2019.
Related: DRUG analyst forecast, DRUG key metrics. See the DRUG stock overview for the latest quote and news.
DRUG ownership FAQ
Who owns the most Bright Minds Biosciences stock?
The largest shareholders of Bright Minds Biosciences are Jupiter Topco LLC (13.68%), HHG PLC (13.02%), Cormorant Asset Management, LLC (9.12%), BlackRock Inc (6.96%), Vivo Capital, LLC (5.65%).
What percentage of Bright Minds Biosciences is owned by institutions?
Institutions hold 94.9% of Bright Minds Biosciences's shares outstanding; insiders hold 11.94%.
Which funds own Bright Minds Biosciences?
The largest fund holders of Bright Minds Biosciences are iShares Russell 2000 ETF (1.86%), Janus Henderson Hrzn Biotec E2 USD (1.68%), Eventide Healthcare & Life Sciences I (1.32%), Heptagon Driehaus US Micro Cap Eq C$ Acc (1.05%), BlackRock Health Sciences Opps Inv A (0.97%).
What is Bright Minds Biosciences's short interest?
883K shares of Bright Minds Biosciences were sold short, 11.60% of the float; at the average daily volume it would take 9.72 days to cover.
Are insiders buying or selling Bright Minds Biosciences?
Of the latest 1 reported insider transactions in Bright Minds Biosciences (since October 15, 2024), 1 were purchases and 0 were sales.
How many shares of Bright Minds Biosciences are outstanding?
Bright Minds Biosciences has 9.9M shares outstanding, of which 6.7M are in the public float.